DSIP

What is DSIP?

DSIP (English Delta Sleep-Inducing Peptide) is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). It was discovered in the 1970s during research into brain peptides and sleep. The name refers to the delta waves characteristic of deep, slow-wave sleep.

Early research linked it to changes in sleep architecture in animals. It was later also studied in connection with stress, body temperature and neuroendocrine responses. Despite its long history, it remains poorly understood.

What does the research show?

The literature on DSIP is fragmented. Some studies reported an effect on sleep, others an effect on hormones or behaviour, and others found no clear effect. Common limitations include:

• small samples;
• differing routes of administration and doses;
• a lack of modern, blinded randomised studies;
• older methodological standards.

This means that DSIP is not a proven medicine for sleep disorders. For researchers it is interesting mainly as a tool for studying the neuropeptide regulation of sleep, not as a therapeutic solution.

Sleep is a complex system

Sleep is regulated by many mechanisms: circadian rhythm, homeostatic sleep pressure, neurotransmitters and hormones. A single peptide rarely acts in isolation. In any study it is therefore important to know:

• when in the daily cycle the peptide was administered;
• what the light exposure was;
• how sleep was measured (EEG, actigraphy, subjective scales);
• whether caffeine, alcohol and other factors were controlled.

Without this context, results are difficult to compare.

Safety and legal status

DSIP is not an approved medicine in the EU. Data on safety in humans are limited. If you have sleep problems, consult a doctor — chronic insomnia may be associated with other conditions that require management.

Quality and storage

The specification declares a purity of ≥ 98 % (HPLC). Store the lyophilizate at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and follow the laboratory protocol.

Conclusion

DSIP is a historically important neuropeptide that still captures researchers’ imagination. Its clinical value, however, remains unconfirmed, so any claim about effects on sleep must be treated with caution.